Sunday, May 19, 2013 Last update: 5:34 AM
Company Tech News as it Breaks
Transcept Pharmaceuticals, Inc.
News articles for Transcept Pharmaceuticals, Inc.:
Wednesday, May 1, 2013
- Transcept Pharmaceuticals to Report First Quarter 2013 Financial Results and Host Conference Call on May 8, 2013Point Richmond, Calif., May 1, 2013 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced that the company will host a conference call on ... read more
Wednesday, April 10, 2013
- Thomas J. Dietz, Ph.D., Appointed To The Transcept Pharmaceuticals Board Of DirectorsPOINT RICHMOND, Calif., April 10, 2013 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced that Thomas J. Dietz, Ph.D., Chairman and CEO of ... read more
Thursday, February 28, 2013
- Transcept Pharmaceuticals to Present at Cowen and Company Health Care Conference on March 6POINT RICHMOND, Calif., Feb. 28, 2013 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, announced today that Transcept management is scheduled to present a general ... read more
Wednesday, February 27, 2013
- Transcept Pharmaceuticals Reports Fourth Quarter And Full Year 2012 Financial ResultsPOINT RICHMOND, Calif., Feb. 27, 2013 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced financial results for the three and twelve months ... read more
Thursday, February 21, 2013
- Transcept Pharmaceuticals to Report Fourth Quarter and Full Year 2012 Financial Results and Host Conference Call on February 27, 2013POINT RICHMOND, Calif., Feb. 21, 2013 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced that the company will host a conference call on ... read more
Tuesday, February 5, 2013
- Transcept Pharmaceuticals to Present at Two Upcoming Investor ConferencesPOINT RICHMOND, Calif., Feb. 5, 2013 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, announced today that Transcept management is scheduled to present a general ... read more
Thursday, January 10, 2013
- Transcept Pharmaceuticals Comments on New FDA Dosage Reduction Requirements for Zolpidem Based Prescription Sleep Aids Administered at BedtimePOINT RICHMOND, Calif., Jan. 10, 2013 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) - The FDA is requiring that the manufacturers of certain zolpidem based prescription sleep aids such as Ambien® and Ambien CR®, and generic versions of these products, reduce the recommended dose. FDA ... read more
Monday, November 26, 2012
- Transcept Pharmaceuticals to Host Conference Call to Discuss Broadened Intermezzo® Commercialization Strategy and New Consumer Advertising Campaign by Purdue PharmaPOINT RICHMOND, Calif., Nov. 26, 2012 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, announced that it will host a conference call to discuss ... read moreTranscept Pharmaceuticals Announces Broadened Intermezzo® Commercialization Strategy Including Initiation of a Direct to Consumer Advertising Campaign by Purdue PharmaPOINT RICHMOND, Calif., Nov. 26, 2012 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) announced today that Purdue Pharmaceutical Products, L.P. (Purdue), the Transcept U.S. commercialization partner for Intermezzo® (zolpidem tartrate) sublingual tablet C-IV, is launching a national direct-to-consumer (DTC) promotional campaign, including digital, print and television advertising ... read more